Holy Cross 9th Annual Winter Oncology Symposium

https://www.hconcologysymposium.com/

 

Emerging Targets in ER Positive Breast Cancer: CDK4/6 inhibitors, Bcl-2 Inhibitors and PI3K/AKT/mTOR Network

624 views
April 23, 2019
Comments 0
Login to view comments. Click here to Login